Literature DB >> 28611164

Fulminant tumefactive multiple sclerosis in pregnancy.

Shabnam Pakneshan1, Evanthia Bernitsas1.   

Abstract

A 35-year-old pregnant woman was admitted with acute onset of paresthesias and word finding difficulty. Initial MRI scan of the brain was suggestive of ischaemic event. During hospitalisation, she had a rapid course with worsening of her neurological deficit that prompted additional testing. Further investigations were consistent with tumefactive multiple sclerosis. After a poor initial response to intravenous steroids and plasma exchange, and discussion of all available therapeutic options, the patient decided to proceed with elective termination. Introduction of physical, occupational, speech and disease-modifying therapy resulted in clinical improvement. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  multiple sclerosis; neuroimaging; pregnancy

Mesh:

Substances:

Year:  2017        PMID: 28611164      PMCID: PMC5534854          DOI: 10.1136/bcr-2017-219534

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort.

Authors:  C Lebrun; E Le Page; O Kantarci; A Siva; D Pelletier; D T Okuda
Journal:  Mult Scler       Date:  2012-02-02       Impact factor: 6.312

Review 2.  Gadolinium-based contrast agents: A comprehensive risk assessment.

Authors:  Tyler J Fraum; Daniel R Ludwig; Mustafa R Bashir; Kathryn J Fowler
Journal:  J Magn Reson Imaging       Date:  2017-01-13       Impact factor: 4.813

3.  Diffusion-weighted MR imaging characteristics of an acute strokelike form of multiple sclerosis.

Authors:  C Rosso; P Remy; A Creange; P Brugieres; P Cesaro; H Hosseini
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

4.  Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes.

Authors:  Joel G Ray; Marian J Vermeulen; Aditya Bharatha; Walter J Montanera; Alison L Park
Journal:  JAMA       Date:  2016-09-06       Impact factor: 56.272

5.  Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.

Authors:  A Altintas; B Petek; N Isik; M Terzi; F Bolukbasi; M Tavsanli; S Saip; C Boz; T Aydin; O Arici-Duz; F Ozer; A Siva
Journal:  Mult Scler       Date:  2012-03-14       Impact factor: 6.312

6.  Acute demyelinating lesions with restricted diffusion in multiple sclerosis.

Authors:  Konstantin E Balashov; Eric Lindzen
Journal:  Mult Scler       Date:  2012-04-20       Impact factor: 6.312

7.  Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse.

Authors:  Sandra Vukusic; Michael Hutchinson; Martine Hours; Thibault Moreau; Patricia Cortinovis-Tourniaire; Patrice Adeleine; Christian Confavreux
Journal:  Brain       Date:  2004-05-06       Impact factor: 13.501

8.  Predictors of long-term disability accrual in relapse-onset multiple sclerosis.

Authors:  Vilija G Jokubaitis; Tim Spelman; Tomas Kalincik; Johannes Lorscheider; Eva Havrdova; Dana Horakova; Pierre Duquette; Marc Girard; Alexandre Prat; Guillermo Izquierdo; Pierre Grammond; Vincent Van Pesch; Eugenio Pucci; François Grand'Maison; Raymond Hupperts; Franco Granella; Patrizia Sola; Roberto Bergamaschi; Gerardo Iuliano; Daniele Spitaleri; Cavit Boz; Suzanne Hodgkinson; Javier Olascoaga; Freek Verheul; Pamela McCombe; Thor Petersen; Csilla Rozsa; Jeannette Lechner-Scott; Maria Laura Saladino; Deborah Farina; Pietro Iaffaldano; Damiano Paolicelli; Helmut Butzkueven; Alessandra Lugaresi; Maria Trojano
Journal:  Ann Neurol       Date:  2016-06-01       Impact factor: 10.422

Review 9.  Natalizumab use during the third trimester of pregnancy.

Authors:  Aiden Haghikia; Annette Langer-Gould; Georg Rellensmann; Henriette Schneider; Tobias Tenenbaum; Birte Elias-Hamp; Sylvia Menck; Julian Zimmermann; Sandra Herbstritt; Martin Marziniak; Tania Kümpfel; Ingrid Meinl; Tatiana Plavina; Ralf Gold; Kerstin Hellwig
Journal:  JAMA Neurol       Date:  2014-07-01       Impact factor: 18.302

Review 10.  Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks.

Authors:  Raed Alroughani; Ayse Altintas; Mohammed Al Jumah; Mohammadali Sahraian; Issa Alsharoqi; Abdurahman AlTahan; Abdulkader Daif; Maurice Dahdaleh; Dirk Deleu; Oscar Fernandez; Nikolaos Grigoriadis; Jihad Inshasi; Rana Karabudak; Karim Taha; Natalia Totolyan; Bassem I Yamout; Magd Zakaria; Saeed Bohlega
Journal:  Mult Scler Int       Date:  2016-12-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.